Cargando…
Atezolizumab Induces Necroptosis and Contributes to Hepatotoxicity of Human Hepatocytes
Atezolizumab is an immune checkpoint inhibitor (ICI) targeting PD-L1 for treatment of solid malignancies. Immune checkpoints control the immune tolerance, and the adverse events such as hepatotoxicity induced by ICIs are often considered as an immune-related adverse event (irAE). However, PD-L1 is a...
Autores principales: | Endo, Yukinori, Winarski, Katie L., Sajib, Md Sanaullah, Ju, Anna, Wu, Wen Jin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10380327/ https://www.ncbi.nlm.nih.gov/pubmed/37511454 http://dx.doi.org/10.3390/ijms241411694 |
Ejemplares similares
-
Drp1 and RB interaction to mediate mitochondria-dependent necroptosis induced by cadmium in hepatocytes
por: Zhang, Shili, et al.
Publicado: (2019) -
Recapitulation of methotrexate hepatotoxicity with induced pluripotent stem cell-derived hepatocytes from patients with rheumatoid arthritis
por: Kim, Juryun, et al.
Publicado: (2018) -
Evaluation of Medicinal Plant Hepatotoxicity in Co-cultures of Hepatocytes and Monocytes
por: Saad, Bashar, et al.
Publicado: (2006) -
Primary Human Hepatocyte Spheroids as Tools to Study the Hepatotoxic Potential of Non-Pharmaceutical Chemicals
por: Vilas-Boas, Vânia, et al.
Publicado: (2021) -
Aryl Hydrocarbon Receptor Activity in Hepatocytes Sensitizes to Hyperacute Acetaminophen-Induced Hepatotoxicity in Mice
por: Schuran, Fenja A., et al.
Publicado: (2020)